Will Moderna's Coronavirus Vaccine Really Change the Game?

Adria Cimino, The Motley Fool
·4 min read
Will Moderna's Coronavirus Vaccine Really Change the Game?

In an interim analysis of Moderna’s phase 3 trial, all 11 cases of severe COVID-19 occurred in the placebo group. Moderna will soon complete a final analysis of the phase 3 trial, to be used as a basis for Emergency Use Authorization. Pfizer reported one case of severe COVID-19 in a trial participant who had received the company’s investigational vaccine.